Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling

Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling

Abstract Background Diverse signalling pathways are involved in carcinogenesis and one of such pathways implicated in many cancers is the interleukin 6/signal transducer and activator of transcription 3 (IL-6/STAT3) signalling pathway. Therefore, inhibition of this pathway is targeted as an anti-can...

Full description

Bibliographic Details
Main Authors: Seth A. Domfeh, Patrick W. Narkwa, Osbourne Quaye, Kwadwo A. Kusi, Gordon A. Awandare, Charles Ansah, Alimatu Salam, Mohamed Mutocheluh
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Cryptolepine
IL-6/STAT3
Carcinogenesis
Hepatoma
Anti-cancer
Online Access:https://doi.org/10.1186/s12906-021-03326-x

Internet

https://doi.org/10.1186/s12906-021-03326-x

Similar Items